{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T00:05:31Z","timestamp":1759017931808,"version":"3.44.0"},"reference-count":12,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2008,12,1]],"date-time":"2008-12-01T00:00:00Z","timestamp":1228089600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,12,1]],"date-time":"2008-12-01T00:00:00Z","timestamp":1228089600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie"],"published-print":{"date-parts":[[2008,12]]},"DOI":"10.1016\/j.annder.2008.02.026","type":"journal-article","created":{"date-parts":[[2008,8,4]],"date-time":"2008-08-04T10:11:09Z","timestamp":1217844669000},"page":"839-842","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Cellulite de Wells et dermohypodermite bact\u00e9rienne n\u00e9crosante induites par l\u2019anakinra"],"prefix":"10.1016","volume":"135","author":[{"given":"M.","family":"Livory","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Wechsler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Revuz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Bagot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"X.","family":"Chevalier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Poszepczynska-Guign\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.annder.2008.02.026_bib1","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1002\/1529-0131(199812)41:12<2196::AID-ART15>3.0.CO;2-2","article-title":"Treatment of rheumatoid arthritis with recombinant human interleukin-1 receptor antagonist","volume":"41","author":"Bresnihan","year":"1998","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.annder.2008.02.026_bib2","unstructured":"US Food and Drug Administration (FDA). Kineret\u00ae (anakinra) FDA briefing information, 16 August 2001."},{"key":"10.1016\/j.annder.2008.02.026_bib3","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1002\/art.10141","article-title":"Treatment of rheumatoid arthritis with anakinra, a recombinant human interleukin-1 receptor antagonist, in combination with methotrexate: results of a 24 weeks, multicenter, randomized, double-blind, placebo-controlled trial","volume":"46","author":"Cohen","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.annder.2008.02.026_bib4","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1002\/art.10870","article-title":"Anakinra, a recombinant human interleukin-1 receptor antagonist (r-metHuIL-1ra), in patients with rheumatoid arthritis. A large international, multicenter, placebo-controlled trial","volume":"48","author":"Fleischmann","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.annder.2008.02.026_bib5","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1365-2133.1979.tb03574.x","article-title":"Eosinophilic cellulitis","volume":"100","author":"Wells","year":"1979","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.annder.2008.02.026_bib6","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0190-9622(88)70016-X","article-title":"Wells\u2019 syndrome is a distinctive disease entity and not a histologic diagnosis","volume":"18","author":"Aberer","year":"1988","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.annder.2008.02.026_bib7","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1046\/j.1440-0960.2003.00678.x","article-title":"Wells\u2019 syndrome following thiomersal-containing vaccinations","volume":"44","author":"Koh","year":"2003","journal-title":"Australas J Dermatol"},{"key":"10.1016\/j.annder.2008.02.026_bib8","first-page":"918","article-title":"Wells\u2019 syndrome: a pathogenic role for circulating CD4+CD7- T cells expressing interleukin-5 mRNA","volume":"136","author":"Yagi","year":"1997","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.annder.2008.02.026_bib9","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/j.1365-2133.2005.06635.x","article-title":"Adverse cutaneous reactions to anakinra in patients with rheumatoid arthritis: clinicopathological study of five patients","volume":"153","author":"Vila","year":"2005","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.annder.2008.02.026_bib10","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1093\/clinids\/13.2.270","article-title":"Group C streptococcal bacteremia: analysis of 88 cases","volume":"13","author":"Bradley","year":"1991","journal-title":"Rev Infect Dis"},{"key":"10.1016\/j.annder.2008.02.026_bib11","first-page":"74","article-title":"The safety of interleukin-1 receptor antagonist (anakinra) in the treatment of rheumatoid arthritis","volume":"56","author":"Riente","year":"2004","journal-title":"Reumatismo"},{"key":"10.1016\/j.annder.2008.02.026_bib12","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1136\/ard.2005.048371","article-title":"Safety of extended treatment with anakinra in patients with rheumatoid arthritis","volume":"65","author":"Fleischmann","year":"2006","journal-title":"Ann Rheum Dis"}],"container-title":["Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0151963808004456?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0151963808004456?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T10:54:36Z","timestamp":1758970476000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0151963808004456"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,12]]},"references-count":12,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2008,12]]}},"alternative-id":["S0151963808004456"],"URL":"https:\/\/doi.org\/10.1016\/j.annder.2008.02.026","relation":{},"ISSN":["0151-9638"],"issn-type":[{"type":"print","value":"0151-9638"}],"subject":[],"published":{"date-parts":[[2008,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cellulite de Wells et dermohypodermite bact\u00e9rienne n\u00e9crosante induites par l\u2019anakinra","name":"articletitle","label":"Article Title"},{"value":"Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.annder.2008.02.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}